Activated HGF-c-Met Axis in Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments including Food and Drug Administration (FDA) approved molecular targeted agent’s pembrolizumab and cetuximab show promise but did not improve the five-year survival which is currently less than 40%. The hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Levi, Enders, Jonathan, Thomas, Sufi Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742817/
https://www.ncbi.nlm.nih.gov/pubmed/29231907
http://dx.doi.org/10.3390/cancers9120169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742817/
https://www.ncbi.nlm.nih.gov/pubmed/29231907
http://dx.doi.org/10.3390/cancers9120169

Ejemplares similares